Thermo Fisher Scientific 

$581.77
1570
+$3.16+0.55% 今天

統計

當日最高
584.1
當日最低
573.31
52週高點
643.99
52週低點
385.46
成交量
1,504,731
平均成交量
1,939,393
市值
218.58B
本益比
32.78
股息殖利率
0.3%
股息
1.73

即將到來

股息

0.3%股息殖利率
Jan 26
$0.43
Oct 25
$0.43
Jul 25
$0.43
Apr 25
$0.43
Jan 25
$0.39
10年成長
11.11%
5年成長
10.59%
3年成長
7.1%
1年成長
不適用

財報

29Apr預期
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
下一步
5.1
5.59
6.08
6.57
預期EPS
5.298273
實際EPS
不適用

財務

14.77%利潤率
有盈利
2019
2020
2021
2022
2023
2024
85.76B營收
12.67B淨利

分析師評級

$656.29平均目標價
最高預估為 750.00。
來自過去6個月內的 15 則評分。這不是投資建議。
買入
93%
持有
7%
賣出
0%

其他人也在關注

此清單是根據在 Stock Events 上追蹤 TMO 的使用者自選建立的。這不是投資建議。

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
Show more...
執行長
Mr. Marc N. Casper
員工
125000
國家
US
ISIN
US8835561023

上市

0 Comments

分享你的想法

FAQ

Thermo Fisher Scientific 今天的股價是多少?
TMO 目前價格為 $581.77 USD,過去 24 小時上漲了 +0.55%。在圖表上更密切關注 Thermo Fisher Scientific 股價表現。
Thermo Fisher Scientific 的股票代號是什麼?
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,Thermo Fisher Scientific 的股票以代號 TMO 進行交易。
Thermo Fisher Scientific 的股價在上漲嗎?
TMO 股票較上週下跌 -7.16%,本月下跌 -1.81%,過去一年 Thermo Fisher Scientific 下跌 -2.67%。
Thermo Fisher Scientific 的市值是多少?
今天 Thermo Fisher Scientific 的市值為 218.58B
Thermo Fisher Scientific 下一次財報日期是什麼時候?
Thermo Fisher Scientific 將於 April 29, 2026 公布下一次財報。
Thermo Fisher Scientific 上一季度的財報如何?
TMO 上一季度的財報為每股 6.57 USD,預估為 6.45 USD,帶來 +1.88% 的驚喜。下一季度的預估財報為每股 不適用 USD。
Thermo Fisher Scientific 去年的營收是多少?
Thermo Fisher Scientific 去年的營收為 85.76BUSD。
Thermo Fisher Scientific 去年的淨利是多少?
TMO 去年的淨收益為 12.67BUSD。
Thermo Fisher Scientific 會發放股息嗎?
是的,TMO 的股息每 每季 發放一次。每股最新股息為 0.43 USD。截至今日,股息殖利率(FWD)% 為 0.3%。
Thermo Fisher Scientific 有多少名員工?
截至 February 02, 2026,公司共有 125,000 名員工。
Thermo Fisher Scientific 位於哪個產業?
Thermo Fisher Scientific從事於Health Care產業。
Thermo Fisher Scientific 何時完成拆股?
Thermo Fisher Scientific 最近沒有進行任何拆股。
Thermo Fisher Scientific 的總部在哪裡?
Thermo Fisher Scientific 的總部位於 US 的 Waltham。